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Abstract
Adult neural precursor cells (NPCs) respond to injury or disease of the CNS by migrating to the site of damage or
differentiating locally to replace lost cells. Factors that mediate this injury induced NPC response include chemokines and
pro-inflammatory cytokines, such as tumor necrosis factor-a (TNFa) and interferon-c (IFNc), which we have shown
previously promotes neuronal differentiation. RT-PCR was used to compare expression of chemokines and their receptors in
normal adult mouse brain and in cultured NPCs in response to IFNc and TNFa. Basal expression of many chemokines and
their receptors was found in adult brain, predominantly in neurogenic regions, with OB&SVZ.hippocampus and little or no
expression in non-neurogenic regions, such as cortex. Treatment of SVZ-derived NPCs with IFNc and TNFa (alone and in
combination) resulted in significant upregulation of expression of specific chemokines, with CXCL1, CXCL9 and CCL2 most
highly upregulated and CCL19 downregulated. Unlike IFNc, chemokine treatment of NPCs in vitro had little or no effect on
survival, proliferation or migration. Neuronal differentiation was promoted by CXCL9, CCL2 and CCL21, while astrocyte and
total oligodendrocyte differentiation was not affected. However, IFNc, CXCL1, CXCL9 and CCL2 promoted oligodendrocyte
maturation. Therefore, not only do NPCs express chemokine receptors, they also produce several chemokines, particularly in
response to inflammatory mediators. This suggests that autocrine or paracrine production of specific chemokines by NPCs
in response to inflammatory mediators may regulate differentiation into mature neural cell types and may alter NPC
responsiveness to CNS injury or disease.
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Introduction
Effective neural repair is likely to require a multi-factorial
approach, including blockage of neuronal death and replacement
of lost cells by differentiation of neural precursor cells (NPCs).
Following CNS damage NPCs can migrate from their normal
location in the subventricular zone (SVZ) to the site of damage
[1,2], at least partly due to the inflammatory response and
production of cytokines and chemokines. Chemokines have been
widely studied with respect to immune cell migration but various
members of the chemokine family are also expressed in the normal
CNS, making them prime candidates for regulating both injury-
induced as well as normal NPC function.
Chemokines are primarily known for regulating chemoattrac-
tion of immune cells to sites of tissue damage. The family is divided
into 4 groups based on the relative position of the first N-terminal
cysteine (CC, CXC, CX3X and XC or d families) [3]. They signal
through G-protein coupled receptors (CCR, CXCR, CX3CR,
CR). Their expression can be induced or upregulated under
inflammatory conditions. However, many chemokines and their
receptors are also constitutively expressed, both during develop-
ment and in some areas of the adult nervous system. They have
been reported to have widespread non-immunological effects in
the CNS, including regulation of neural cell proliferation,
migration, survival and synaptic transmission and can act in a
paracrine or autocrine manner [3,4]. Some, such as CXCL12, also
have a developmental role and are reported to be involved in
neuronal precursor migration in a number of areas, such as
cerebellum [4]. In response to injury, astrocytes and microglial
cells appear to be a major source of chemokines that attract
leukocytes to the injury site [5,6,7]. There is little information
available about region specific expression of these factors in adult
CNS under normal conditions. Neurospheres derived from
embryonic or adult mouse NPCs express several chemokine
receptors, with some differences in E17 versus adult expression.
E17 neurospheres expressed CCR1–3, 5, 7–10 and CXCR1–4 &
6, while the adult spheres expressed CCR1–8, 10 and CXCR1–6
[8] and human embryonic NPCs expressed CCR3 and CXCR4
[9]. CXCL12 via CXCR4 promotes NPC migration, proliferation
or survival [8,10,11]), although it has also been reported to inhibit
proliferation and promote quiescence [9].
Inflammatory mediators, such as IFNc and TNFa are
regulators of chemokine and chemokine receptor expression in
many tissues [12,13]. This includes the CNS, in which IFNc
upregulates CCL2 [14], CXCR4 and CCR5 [15] in astrocytes.
IFNc plus TNFa in conjunction with CCL2/CCR2 promote
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25406migration of NPCs to the site of cytokine injection [7] and IFNc is
a potent inhibitor of NPC proliferation that promotes neuronal
differentiation [16]. Whether this is a direct effect or may be
mediated by chemokines is not yet known.
We have now examined chemokine and chemokine receptor
expression in neurogenic versus non-neurogenic regions of the
adult CNS, as well as regulation by IFNc and TNFa in NPCs. The
role of selected chemokines alone or in combination with IFNc,o n
Table 1. Primer sequences used for RT-PCR.
Gene Forward primer (Sequence 59R39) Reverse primer (Sequence 59R39)
CCL2 CCC AAT GAG TAG GCT GGA GA CCT TAG GGC AGA TGC AGT TT
CCL19 TTC ACC ACA CTA AGG GGC TA GCC ACA GAG AGA TGG TGT TC
CCL20 CTT GCT TTG GCA TGG GTA CT TCA GCG CAC ACA GAT TTT CT
CCL21 GGG GAA CCT CTA AGT CTG GA TGC TGT CTC CTT CCT CAT TC
CCL25 GGC GAT GAG AAT CTT GAC AG TAG CCA ATA GCT CCT TGG TG
CCR1 ATG GAG ATT TCA GAT TTC TCA GAA GCC AGC AGA GAG
CCR2 ATG TTA CCT CAG TTC ATC CAC GGC GTA ATG GTG ATC ATC TTG TTT GGA
CCR3 ATG GCA TTC AAC ACA GAT G CAA CTA AAA CAC CAC AGA
CCR4 ATG AAT GCC ACA GAG GTC TTA CAA AGC GTC ACG GAA G
CCR5 ATG GAT TTT CAA GGG TCA G TCA TAA ACC AGT AGA AAC
CCR6 TAG GAC TGG AGC CTG GAT AAC CAC TAG GGC TTG AGA TGA TGA TGG AGA
CCR7 ATG GAC CCA GGG AAA CCC A CTA CGG GGA GAA GGT TGT G
CCR8 ATG GAT TAC ACG ATG GAG CAC TCC CCT TAC AAG ATG TC
CCR9 GTC ACC TTG GGG TTT TTC CT ACA TGG CAT AAG CGT CAA CA
CCR10 ATG GGG ACC AAG CCC ACA GAG CTA GTT GTC CCA AGA GAG AC
CCR11 GTT TCT CTG ACC CCA CTG GCA GGA AAC ACA GGT TTG
CXCL1 ATG ATC CCA GCC ACC CGC TC TTA CTT GGG GAC ACC TTT TAG C
CXCL2 GAT ACT GAA GAG CGG CAA GTC AAG ACA CAT CCA GAC ACC GTT
CXCL3 AGA TCT CAC CAC AGC CCT TC AAC CCT TGG TAG GGT GTT CA
CXCL4 CCC TAG ACC CAT TTC CTC AA AGA AAC AAC AGG CCC AGA AG
CXCL5 GCC CTA CGG TGG AAG TCA TA AGT GCA TTC CGC TTA GCT TT
CXCL7 CAC TGC TCT TCA TTA TGG GC GGT CAG TAA CCT TCC AAG
CXCL8 TCT TCT TGC TCT GTT GTC TGC CCT GCG GCG TTC GCA AGT ATC TTC AAT
CXCL9 ATG AAG TCC GCT GTT CTT TTC C GTC TCT TAT GTA GTC TTC CTT G
CXCL10 AGT AAC CCA AGT GCT GCC GTC CTC CAG TTA AGG AGC CCT TTT AG
CXCL11 ATG AAC AGG AAG GTC ACA GC GAT GTC ACA TGT TTT GAC GC
CXCL12 GTC CTC TTG CTG TCC AGC TC TTT CAG ATG CTT GAC GTT GG
CXCL13 ATG AGG CTC AGC ACA GCA AC TCA GGC AGC TCT TCT CTT AC
CXCL14 AGC ATG AGG CTC CTG G CTA TTC TTC GTA GAC C
CXCL15 ATG GCT GCT CAA GGC TGG TC TTA GGC ATC ACT TGT C
CXCL16 ATG AGG CGG GGC TTT GGA C CTA GGG TCT TGG TTC AAC AG
CXCR1 GCT GCC CAC TGG AGA TTA TTT C TAT GCC TGG CGG AAG ATA GC
CXCR2 ATG GGA GAA TTC AAG GTC TTA GAG GGT AGT AGA GGT G
CXCR3 GCA AAT GTG GAT GTT GTT CA ATG GTG TTG TCC TTG TTG CT
CXCR4 ATG GAA CCG ATC AGT GTG GTT AGC TGG AGT GAA AAC
CXCR5 TGG ATG ACC TGT ACA AGG AAC TGG AAC GGG AGG TGA ACC CTC TAG AGG
CXCR6 ATG CCA TGG ATG ATG GGC CTA CAA TTG GAA CAT ACT GG
CXCR7 CAG GCT AAG ACC ACA GGC TA CCA CAC CAA GAT GCA TAC AA
CX3CL1 ACT CCA GCC ATG GCT CCC TC TCA CAC TGG CAC CAG GAC G
CX3CR1 CAC CAT GTC CAC CTC CTT CCC TG CTT CAG AGC AGG AGA GAC
XCL1 CAA GAC CTC AGC CAT GAG AC GGA ACA GTT TCA GCC ATG TT
XCR1 ATG GAG TCC TCT ACA G CTC CTC TCA GTA GAA G
GAPDH TCC ACC ACC CTG TTG CTG TA ACC ACA GTC CAT GCC ATC AC
doi:10.1371/journal.pone.0025406.t001
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ation was also examined.
Materials and Methods
Reagents
Chemokines: Recombinant mouse MIP-3b/CCL19, 6Ckine/
CCL21, TECK/CCL25 and LIX/CXCL5 were purchased from
R&D Systems. Recombinant mouse JE/CCL2, MIP-3a/CCL20,
KC/CXCL1, MIG/CXCL9, CXCL16 and human IL-8/CXCL8
were purchased from Peprotech Inc (Princeton, NJ, USA).
Recombinant mouse Tumor Necrosis Factor-a (TNFa) was from
Millipore (Melbourne, Australia) and recombinant mouse Interfer-
on-c (IFNc) from BD Pharmingen (Sydney, Australia).
Ethics statement
Animal use was approved by the University of Melbourne
Animal Ethics Committee and experiments were performed in
accordance with National Health and Medical Research Council
of Australia guidelines (approval #06218).
Neurosphere culture
Neurospheres were generated from cells isolated from the
subventricular zone of 6–8 week old C57BL/6 mice and cultured
in proliferation media consisting of DMEM/F12 (GibcoBRL/
Invitrogen) containing 0.6% glucose, 3 mM NaHCO3, 5 mM
HEPES, 2 mM L-glutamine, 0.1 mg/ml apo-transferrin, 25 mg/
ml insulin, 60 mM putrescene, 30 mM sodium selenite, 20 nM
progesterone and 1% BSA (all from Sigma), supplemented with
EGF (20 ng/ml; Peprotech) and FGF2 (10 ng/ml; Peprotech), as
previously described [17]. Cells were cultured for 6–7 days and
used up to passage 10.
RT-PCR for chemokine and chemokine receptor
expression analyses
Olfactory bulb, subventricular zone, hippocampus and cortex
tissue was collected from 8 week old C57Bl/6 adult mice.
Neurosphere cultures were treated with IFNc (100 U/mL), TNFa
(100 U/mL) or combination of both for 24 h and cells collected.
Total RNA was isolated from tissue and cultured neurospheres
using an RNeasy Mini Kit (Qiagen, Australia) according to the
manufacturer’s instructions. The cDNA was prepared from 2.0 mg
RNA using 50 mg oligo-(dT)20 (GeneWorks, Australia) and
SuperScript Reverse Transcriptase (Invitrogen, Australia) follow-
ing the manufacturer’s protocol. For semi-quantitative RT-PCR,
cDNA was subsequently amplified using Hot-StarTaq DNA
Polymerase (Qiagen, Australia) and primers as listed in Table 1
using a PCR Express machine (Thermo Scientific, USA). The
PCR program consisted of initial denaturation at 95uC for 15 min,
followed by 40 cycles of denaturation at 94uC for 30 s, annealing
at 58uC for 30 s and extension at 72uC for 30 s, with a final
extension at 72uC for 10 min for all primers. A 10 ml aliquot of
each PCR product was size-separated by electrophoresis in 2%
agarose gels containing Sybr Safe (Invitrogen, Australia) and
imaged by digital gel documentation using an LAS-3000 machine
(Fuji, Japan). Densitometric analysis of level of expression was
performed using ImageJ software (NIH), normalised against
GAPDH levels.
For quantitative RT-PCR (qPCR), cDNA was prepared as
above, except that RNA was DNase treated using Ambion DNA-
free DNase Treatment and Removal Reagent (Applied Biosystems,
Australia). For each sample, real-time qPCR was conducted in
triplicate using Platinum SYBR Green qPCR SuperMix-UDG
(Invitrogen, Australia) and primers as listed in Table 2 using the
Rotor-Gene 6000 PCR system (Corbett Research, Australia). ‘‘No
template controls’’, in which no cDNA template is added, were
also included for each master mix prepared. Cycling conditions
were as follows: 50uC for 2 min (UDG incubation), 95uC for
2 min, followed by 40 cycles of 95uC for 15 s, 60uC for 30 s and
72uC for 20 s. Dissociation (melting) curve was added as the final
step (72uC–95uC) to ensure that only the specific target was
amplified in the PCR reaction. Results were analyzed with Roto-
Gene 6 Software (Corbett Research, Australia) and the relative
quantitation was achieved by applying the comparative CT
method (DDCT) [18] whereby the mRNA levels were normalized
against the level of housekeeping gene glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA. All samples from individual
experiments were prepared and run at the same time in the same
machine to allow comparison of relative levels of different
transcripts within each experiment. Transcripts were considered
to be not expressed if they had CT values .32. For analysis of
CXCR expression in CNS tissues, all samples were compared to
levels of CXCR5 in the olfactory bulb, which was expressed at the
lowest level detectable and given a reference value of 1. For
Table 2. Primer sequences used for qPCR.
Gene Forward primer (Sequence 59R39) Reverse primer (Sequence 59R39)
CCL2 GGC CTG CTG TTC ACA GTT GC CCT GCT GCT GGT GAT CCT CTT
CXCL1 GAC CAT GGC TGG GAT TCA CC CCA AGG GAG CTT CAG GGT CA
CXCL9 CCG AGG CAC GAT CCA CTA CA CGA GTC CGG ATC TAG GCA GGT
CXCL13 TTC TGG AAG CCC ATT ACA CAA A CCA TTT GGC ACG AGG ATT CA
CXCR1 ACC CGA TCC GTC ATG GAT GT GGC CAG GTA TCG GTC CAC AC
CXCR2 GCT GTC CCA TGC CAC TCA GA GGC AAG GTC AGG GCA AAG AA
CXCR3 AAC CTT CCT GCC AGC CCT CT CGA AAA CCC ACT GGA CAG CA
CXCR4 TCC GGG ATG AAA ACG TCC AT CAG CCG GTA CTT GTC CGT CA
CXCR5 CTG GAC ATG GGC TCC ATC A GCT GTA GGC CAC AGG CAT GA
CXCR6 CCC TGG CTG ACC TGG TGT TT TGC AGG TGA GAG TGA GCA TGG
CXCR7 AGC AGC GAC TGC ATT GTG GT TGC AAT GGC CAG GTT CAA GA
GAPDH TCC CAG AGC TGA ACG GGA AG TCA GTG GGC CCT CAG ATG C
doi:10.1371/journal.pone.0025406.t002
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IFNc and TNFa, for each chemokine the reference value of 1 was
given to the expression level under basal conditions (for CXCL1
and CCL2) or if not expressed at basal levels (CT.32), the
condition under which lowest expression was detected (TNFa for
CXCL9 and IFNc for CXCL13).
MTS proliferation assay
Neurospheres were pre-treated with IFNc (100 U/mL) for
24 h prior to setting up the assay then dissociated into single cells
and plated at 5610
4 cells/well in proliferation media. Chemo-
kines (100 ng/mL) and IFNc were added at time of plating and
at 2-day intervals thereafter. At day 7, cells were collected and
transferred to 96-well plates containing 100 ml of media from 24-
well plates and viable cell number assessed using the CellTiter 96
Aqueous One Solution Reagent (Promega, Madison, WI, USA),
according to the manufacturer’s instructions. The background
absorbance of the media only control was subtracted from all
samples and then the absorbance values of the treated samples
were all compared to the untreated (basal) samples (expressed as a
percentage of untreated) using the following formula: Treate-
d(Absorbance-background)/Basal(Absorbance-background)6100
and the results from three independent experiments using three
different neurosphere lines were used to calculate the mean+/
2SEM.
Migration, proliferation and cell death assays
Neurospheres were pre-treated with IFNc 100 U/mL for 24 h
prior to setting up the assay. Whole spheres (80–100 mm size) were
plated onto human plasma fibronectin (0.05 mg/mL, Chemicon)
coated 96-well plates in proliferation media with or without
chemokines (100 ng/mL) or IFNc (100 U/mL). Cells were
allowed to adhere and migrate for 24 h prior to assessing effects
on proliferation, cell death and migration. To assess the
percentage of proliferative cells, cells were fixed and immuno-
stained using rabbit anti-Ki67 antibody (1:200, Lab Vision) with
goat anti-rabbit Cy2 (1:1000; Jackson Immunoresearch) and DAPI
(1:3000). To assess the extent of cell death, a TUNEL assay was
performed using an In Situ Cell Death Detection kit (Roche,
Sydney Australia) according to the manufacturer’s instructions.
For each experiment, the number of Ki67 or TUNEL positive
cells and DAPI stained cells was counted for at least 10 fields/well,
with 3 wells/plate per condition and the percentage of cells that
were Ki67 or TUNEL positive was calculated.
The extent of migration was quantified by tracing around
individual neurospheres using ImageJ software (Wayne Rasband,
Research Services Branch, National Institute of Mental Health,
Bethesda, Maryland, USA) and the macro ‘‘Hull and Circle’’
(NIH, USA) written by Audre Karperien, Charles Sturt Univer-
sity, Australia and Thomas R. Roy, University of Alberta, Canada.
To account for variations in cell number per neurosphere, the area
of migration of each neurosphere was divided by the number of
DAPI positive cells per neurosphere.
For each of the assays above, to enable comparison of results
between different experiments and neurosphere lines, the result of
the basal condition in each assay was set to 100% and the results of
the treated conditions were expressed as a percentage of basal
using the following formula: Result(Treated)/Result(Basal)6100.
Three independent experiments using three different neurosphere
lines were then used to calculate the mean+/2SEM.
Neurosphere Differentiation assay
Neurospheres were dissociated into single cells and plated at
1.5610
5 cells per well onto poly-L-ornithine (Sigma) and laminin
(Invitrogen) coated 8-well chamber glass slides (BD Falcon).
Differentiation media was the same as proliferation media but with
2% FBS added and no EGF or FGF2. Chemokines (10 or 100 ng/
mL) and IFNc (100 U/mL), alone and in combination, were
added to the media at time of plating and cells were fixed at 3 and
7 days. For the 7 day time point fresh media was added at day 3.
Cells were immunostained for neuronal (mouse anti-bIII-tubu-
lin;1:3000, Promega), astrocyte (rabbit anti-GFAP; 1:500, Dako)
and oligodendrocyte (mouse anti-O4; 1:200, Chemicon) markers
essentially as previously described [16]. Secondary antibodies used
were goat anti-mouse-Cy3 and goat anti-rabbit-Cy2 (1:1000,
Jackson Immunoresearch), goat anti-mouse IgM Alexa Fluor 488
(1:300, Molecular Probes) and 49, 6-diamidino-2-phenylindole
(DAPI, 1:3000; Sigma) was used to label nuclei. After washing with
PBS coverslips were mounted onto slides using fluorescent
mounting medium (Dako, Carpentaria, USA).
Figure 1. Expression of CXCR chemokine receptors in neurogenic versus non-neurogenic regions of adult brain. qPCR analysis of
chemokine receptor CXCR1–7 expression in neurogenic subventricular (SVZ), olfactory bulb, and hippocampus and non-neurogenic cortex. Due to
large differences in the level of expression of the different receptors, results are presented using a log10 scale and show mean+/2SEM of 3
independent experiments in which all samples were run together and normalized against GAPDH. All samples were compared to expression of
CXCR5 in the olfactory bulb as the reference sample (denoted by #), which was expressed at just detectable levels (CT,32) and given a value of 1.
Receptors that were not expressed (CT$32) are denoted by 0 in their respective columns.
doi:10.1371/journal.pone.0025406.g001
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wells for each condition and the results expressed as a percentage
of total, DAPI-labeled cells in each experiment. For O4 positive
cells, in addition to total O4 cell numbers, counts were performed
based on morphology: cells were classified as precursor cells
(bipolar or tripolar cells), pro-oligodendrocytes (a large number
of thin processes) or oligodendrocytes (flattened membranous
growth).
To enable comparison of results between different experiments
and neurosphere lines, the result of the basal condition in each
assay was set to 100% and the results of the treated conditions
were expressed as a percentage of basal using the following
formula: Result(Treated)/Result(Basal)6100. At least three inde-
pendent experiments using three different neurosphere lines were
then used to calculate the mean+/2SEM.
Statistical analysis
All results are presented as mean+/2SEM, combined from at
least n=3 individual experiments. Group data was analyzed by
ANOVA, followed by Tukey post-hoc comparisons or Dunnet’s
post-hoc comparison to control, using GraphPad Prism 4.0
software. Significance was set as p,0.05.
Results
Chemokine and receptor expression in neurogenic and
non-neurogenic regions of the adult CNS
Neurogenic regions of the adult brain (SVZ and hippocampus)
have previously been shown to express the chemokine receptors
CXCR3, CXCR4, CCR1, CCR2 and CCR5 [19]. We have
extended these studies to analyze expression of CXC chemokines,
CXC receptors, CCR receptors and CX3C and XC chemokines
and receptors in neurogenic regions and the olfactory bulb, the
destination of SVZ-derived NPCs versus non-neurogenic cortex by
qPCR (Fig. 1) and semi-quantitative RT-PCR (Table 3). The
olfactory bulb expressed the majority of receptors and ligands
tested, most at high to very high levels. The neurogenic SVZ
and hippocampus expressed different subsets of receptors and
chemokines, some of which overlapped (e.g. CXCR6) and some of
which were different (e.g. CXCR2 in SVZ but not hip-
pocampus). Expression of the CXC and CC receptors was largely
restricted to neurogenic regions, with only CXCR3, CXCR4,
CXCR6, CCR2, CCR6 and CCR9 expressed at low levels in
cortex. CX3C receptor was widely expressed as were the majority
of CXC ligands, while high CXC3L1 expression was restricted to
neurogenic regions. Overall, the olfactory bulb expressed the most
chemokines and receptors at the highest levels and the cortex
expressed the fewest and at the lowest levels.
Chemokine and chemokine receptor expression in
neurospheres in response to inflammatory cytokine
stimulation
Previous studies have examined the expression of chemokines
and/or chemokine receptors in embryonic and adult neural
precursor cells/neurospheres [8,9,20,21]. Adult neurospheres
expressed almost all CXC and CCR receptors, as well as
CX3CR1 [8], under basal culture conditions, a finding which
we have confirmed (Fig. 2). We also show that adult neurospheres
express all CXC ligands (CXCL1–CXCL16) and 5 CCL ligands
we examined (CCL2, CCL19, CCL20, CCL21, CCL25).
As inflammatory cytokines, such as IFNc and TNFa have been
shown to regulate chemokine and chemokine receptor expression
in a variety of neural and non-neural cell types [7,12,13,14,15]
and the response of neural precursor cells to neural damage
includes effects of inflammatory cytokines [7], we examined
whether IFNc and TNFa alone and in combination modulated
Table 3. Summary of chemokine ligand and receptor
expression in adult brain.
SVZ OB Hipp Cortex
CXCR1 ++ 222
CXCR2 +++ + 22
CXCR3 ++ ++ + +/2
CXCR4 +++ ++++ ++ +
CXCR5 2 +/22 2
CXCR6 +++ +++ ++ ++
CXCR7 +/2 ++2
CCR1 +++2
CCR2 2 ++++ + +
CCR3 2 ++ + 2
CCR4 ++ +++ 22
CCR5 ++ + + /22
CCR6 +/2 ++++ +++ ++
CCR7 +++ ++++ 22
CCR8 ++ + +2
CCR9 + ++++ + +
CCR10 2 +++ + 2
CCR11 2 +/22 2
CXCL1 + + ++++ ++
CXCL2 +/2 ++++ +/22
CXCL3 2222
CXCL4 +/2 ++ + +
CXCL5 +++ ++++ 2 +
CXCL7 ++++ ++++ ++++ ++
CXCL8 2 +/22 2
CXCL9 2 ++ + 2
CXCL10 + ++++ +++ ++
CXCL11 ++ +++ +++ +
CXCL12 ++ /2 ++ ++
CXCL13 +++ 22+
CXCL14 +++ +++ +++ ++
CXCL15 + + ++ ++ +
CXCL16 +++ +++ +++ ++
CX3CL1 +++ +++ +++ +
CX3CR1 ++ +++ ++++ +++
CCL2 2 ++ /22
CCL19 +/2 ++ + +
CCL20 2222
CCL21 +/2 +/2 ++ +
CCL25 22++ +
XCL1 2 ++ 22
XCR1 ++ + 22
SVZ, Subventricular zone; OB, olfactory bulb; Hipp, hippocampus; Ctx, cortex.
Expression levels: 2 none; +/2 very low; + low; ++ moderate, +++ high; ++++
very high.
doi:10.1371/journal.pone.0025406.t003
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(Fig. 2). The inflammatory cytokines regulated overall chemokine
and receptor expression levels in the neurospheres: IFNc F(41, 84)
=15.22, p,0.0001; TNFa F(41, 84)=4.79,p,0.0001; IFNc plus
TNFa F(41, 84)=13.99, p,0.0001. In general however, they had
little or no effect on the majority of the CXC and CC receptors
and several of the CXC ligands. Conversely, IFNc alone
markedly increased expression of CXCL9, which was partially
augmented by co-addition of TNFa.T N F a alone significantly
increased expression of CXCL1, while the combination of IFNc
and TNFa was required to increase expression of CXCL13.
CCL2 expression was modestly increased by IFNc or TNFa
alone and enhanced by the combination. The induction/
upregulation of expression of CXCL1, CXCL9, CXCL13 and
CCL2 by the inflammatory cytokines was confirmed by repeating
the experiments with new neurosphere lines and performing
qPCR (Fig. 3).
Several chemokines have been reported to have widespread
non-immunological effects in the CNS, including regulation of
neural cell proliferation, migration, survival and differentiation
Figure 2. Regulation of chemokine and chemokine receptor expression in adult NPCs by IFNc and TNFa. (A) Selected representative
gels of RT-PCR for chemokine (CXCL and CCL) and chemokine receptor (CXCR and CCR) expression in adult neurospheres under control (C) conditions
or treated with 100 U/ml IFNc (I), 100 U/ml TNFa (T) or IFNc plus TNFa (I+T). (B–D) The relative expression level of each chemokine or receptor in
response to addition of (B) IFNc, (C) TNFa or (D) IFNc plus TNFa was normalized by densitometric analysis to control expression levels for each
chemokine or receptor and expressed as fold difference compared to control. Results show mean+/2SEM of at least n=3 individual experiments;
*p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0025406.g002
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Although most chemokines and their receptors are expressed by
neural precursor cells, most research on their function in CNS
cells, including NPCs, has to date focused primarily on the
macrophage attracting chemokine CXCL12 (previously known as
SDF1; stromal-derived factor-1) and its receptor CXCR4 or
CCL2 (MCP-1, monocyte chemoattractant protein), particularly
with regard to migration. We have therefore examined the effect
of several other chemokines on neural precursor cells: CXCL1 and
CXCL9, whose expression was upregulated in neural precursor
cells by IFNc or TNFa, as well as CXCL5 and CXCL8, which,
like CXCL1, signal through CXCR2. We also examined CXCL16,
expression of which wasn’t significantly modulated by inflammatory
cytokines and CCL2, which has previously been shown to have
multiple effects on neural precursor cells. We also examined the
effect of CCL19, 20, 21 and 25, which have been reported to play a
role in neuroinflammation [24].
Effect of IFNc and chemokines on neurosphere growth
We have previously shown that IFNc is not toxic but inhibits
proliferation of neurospheres [16,25]. To determine whether the
chemokines selected above also modulate neurosphere growth,
alone or in combination with IFNc, neurospheres were grown for
7 days in proliferation media with chemokines+/2IFNc and
neurosphere growth determined by assessment of viable cell
number using the MTS assay (Fig. 4a,b). Significant inhibition of
neurosphere growth was observed in the presence of IFNc, under
all conditions tested (ANOVA F(19, 38)=22.49, p,0.0001). The
chemokines in general had little or no effect on neurosphere
growth by themselves, although CXCL8 produced a modest
decrease (ANOVA F(10, 22)=3.2, p=0.01).
Effect of IFNc and chemokines on neural precursor cell
proliferation, survival and migration
Neurospheres were pretreated for 24 hrs with IFNc to induce
chemokines and IFNc signaling pathways and then plated onto a
fibronectin substrate in proliferation medium containing IFNc
and/or chemokines for 24 hrs. Cell proliferation, survival and
migration were then assessed by quantitation of the percentage of
Ki67 positive cells, TUNEL positive cells and the area covered by
the neural precursor cells from each neurosphere, respectively.
Similar to growth of neurospheres, pretreatment of plated
neurospheres with IFNc decreased the percentage of proliferative
cells (from approximately 3063% under basal conditions to
1561% Ki67+ cells with IFNc pretreatment; ANOVA F(20, 40)
=15.54, p,0.0001) and this was further reduced by continued
treatment with IFNc alone to 462% (Fig. 4c,d). Chemokines by
themselves had no significant effect on the percentage of
proliferative cells (ANOVA F(10, 22)=1.09, p=0.413, ) except for
CXCL5 which partially abrogated the decrease in Ki67 positive
cells induced by IFNc. While proliferation was still significantly
decreased by IFNc in the presence of chemokines, compared to
basal conditions, the chemokines significantly increased the
percentage compared to IFNc treatment alone (ANOVA F(11, 24)
=7.214, p,0.0001). This may have largely been due to an effect
on cell survival. Pretreatment of neurospheres with IFNc alone
had no effect on cell death but continued administration of IFNc
alone for a further 24 hrs induced significant neural precursor cell
death (Fig. 4e,f). However, continued administration of IFNc in
the presence of CXCL1, CXCL5, CXCL8, CXCL9, CCL2,
CCL19 and CCL21 did not produce significant cell death
(ANOVA F(20, 42)=0.865, p=0.63) and in the presence of
CXCL16 and CCL25 only modest cell death, which was less
than induced by IFNc alone.
When neurospheres are plated onto the fibronectin substrate,
they adhere and the cells then migrate away in a non-directed
fashion. To determine whether the chemokines affected such basal
migration, the area of each neurosphere was measured 24 hrs after
plating. None of the chemokines tested had any effect when
compared to non-treated neurospheres (ANOVA F(10, 22)=0.234,
p=0.99), although IFNc pretreatment produced a modest
decrease in migration, which was not abrogated by the
chemokines (Fig. 4g,h).
Effect of IFNc and chemokines on neural precursor cell
differentiation
To determine whether CXCL1, CXCL9, CCL2, CCL19 or
CCL21 had any effect on NPC differentiation, NPCs from
dissociated neurospheres were cultured with chemokines or IFNc
under differentiation conditions and the percentage of neurons,
astrocytes and oligodendrocytes was quantitated. Under basal
conditions approximately 25% of the cells differentiated into
bIII-tubulin positive neurons at 3 days and 65–70% GFAP
positive and 8% O4 positive oligodendrocytes at 7 days. While
there was some variability in the percentage of differentiated
m a t u r ec e l lt y p e si ne a c hn e u r o s p h e r el i n e ,i ne a c hc a s eC X C L 9 ,
CCL2 and CCL21 increased the percentage of neurons
compared to basal in each of three independent experiments
using different neurosphere lines (ANOVA F(6, 20)=3.035,
p,0.05) (Fig. 5a) but none of the chemokines tested alone had
Figure 3. Confirmation of chemokine induction by qPCR. qPCR
was used to confirm the upregulation or induction of chemokine
expression by IFNc and/or TNFa. Due to large differences in the level of
expression of the different chemokines, results are presented using a
log10 scale and show mean+/2SEM of 3 independent experiments in
which all samples were run together and normalized against GAPDH.
CXCL1 and CCL2 were detectable in the neurospheres under basal
conditions, therefore their expression following incubation with IFNc
and TNFa was compared to the level of expression under basal
conditions (which was set to 1). CXCL9 and CXCL13 were not expressed
at detectable levels under basal conditions (CT$32). CXCL9 was
detectable following addition of TNFa, which was used as the reference
condition in this case (and set to 1; denoted by #) for comparison with
expression induced by IFNc and IFNc+TNFa.C X C L 1 3w a sn o t
detectable with TNFa treatment (denoted by 0) but was induced by
IFNc which was used as the reference condition (and set to 1; denoted
by #) for comparison with levels of expression induced by TNFa plus
IFNc.
doi:10.1371/journal.pone.0025406.g003
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e25406Figure 4. Regulation of NPC proliferation survival and migration by chemokines and IFNc. (A,B) Effect on neurosphere growth.
Neurospheres were grown for 7 days in the presence of chemokines (100 ng/ml) and/or IFNc (100 U/ml) and neurosphere growth determined by
assessment of viable cell number using the MTS assay. Results of a representative experiment are shown in A and the combined results of three
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(Fig. 5b) or O4 positive oligodendrocytes (Fig. 5c). However,
several of the chemokines, particularly when combined with
IFNc, altered the proportion of O4 positive cell subtypes. Based
on morphology, the O4 positive cells were classified as precursor
cells (bipolar or tripolar cells), pro-oligodendrocytes (a large
number of thin processes) or oligodendrocytes (flattened
membranous growth) (Fig. 6c). CXCL1 plus IFNc,a sw e l la s
CXCL9, reduced the proportion of precursor cells and increased
the percentage of oligodendrocytes at day 3 of differentiation
(Fig. 6a). By day 7 of differentiation there were very few O4
positive precursor cells remaining and the proportion of
oligodendrocytes was increased, which was enhanced by IFNc
alone or by CCL2 plus IFNc (Fig. 6b).
Discussion
Chemokines are best known for their chemo-attractant
properties and many studies have shown that they promote
NPC migration. This has particularly been the case for SDF1/
CXL12 and MCP1/CCL2, both in vitro [21,26,27,28] and in vivo
to sites of ischemia [10,22,29,30], traumatic damage [31] or
neuroinflammation [7,32]. Other chemokines have also been
shown to regulate NPC migration, including CCL3 and CXCL1
in vivo following striatal cell loss [33], CXCL8 and CXCL13 in vitro
across endothelial cells [34] and CXCL16 regulated migration of a
glial precursor cell line [35]. However it is clear that chemokines
play a much broader role in the adult nervous system than
regulation of NPC migration, under normal physiological
Figure 5. Effect of selected chemokines on NPC differentiation. (A) The effect of chemokines (10 ng/ml) on neuronal differentiation as
assessed by quantifying the relative percentage of cells that expressed the neuronal marker bIII-tubulin at 3 days under treatment conditions
compared to the basal control. (B) The effect on astrocyte differentiation was assessed by counting the percentage of cells immunostained for the
astrocyte marker GFAP at 7 days, expressed as a relative percentage compared to the basal control. (C) The effect on oligodendrocyte differentiation
was assessed by counting the number of cells immunostained for the oligodendrocyte marker O4 at 7 days and expressing this as a percentage
relative to the basal control. (D) Representative micrographs of bIII-tubulin, GFAP and DAPI labeling of cultures differentiated for 3 days in the
presence of 10 ng/ml CXCL9, CCL2 or CCL21, compared to basal conditions. Results in A–C are expressed as mean+/2sem from at n$3 independent
experiments, *p,0.05, **p,0.01. Scale bar in D, 50 mm.
doi:10.1371/journal.pone.0025406.g005
independent experiments, which are expressed as a percentage of neurosphere growth under basal conditions are shown in B. Effect on NPC
proliferation (C,D), survival (E,F) and migration (G,H): neurospheres were pre-treated for 24 hrs with IFNc then plated onto fibronectin in proliferation
medium alone (IFNc pre), with IFNc alone (IFNc+IFNc), with chemokines alone or with chemokines plus IFNc for 24 hrs. Basal controls were not pre-
treated with IFNc nor treated with any factor at the time of plating. Representative results from individual experiments are shown in C, E and G and
the combined results of three independent experiments, expressed as a percentage of basal, are shown in D, F and H. (C,D) Effect on proliferation was
assessed by counting the percentage of cells immunostained for the proliferation marker Ki67. (E,F) Effect on cell survival was assessed by counting
the percentage of cells that were labeled by TUNEL staining. (G,H) Effect on cell migration was assessed by measuring the area of spread of cells from
individual neurospheres and dividing by cell number per neurosphere. Results are expressed as mean+/2sem, *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0025406.g004
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therefore compared expression of all the CXC and selected CC
chemokines, as well as all chemokine receptors, in neurogenic and
non-neurogenic regions of the normal adult mouse brain and in
adult SVZ-derived neurospheres. As NPCs are involved in CNS
injury responses, we have also compared NPC expression levels of
chemokines and their receptors in response to the inflammatory
cytokines IFNc and TNFa. We then examined the biological effect
on adult neurospheres of CXCL1, CXCL9 and CCL2, whose
expression was upregulated by the inflammatory cytokines. To
further explore possible non-inflammatory roles of chemokines on
NPC biology we examined NPC responses to CXCL5, CXCL8,
CXCL16, CCL19, CCL20, CCL21 and CCL25, expression of
which was not regulated by inflammatory cytokines.
Expression of chemokines and receptors in neurogenic
and non-neurogenic regions of the CNS
To date, the most comprehensive comparison of chemokine
receptor expression in the CNS was performed in embryonic and
adult NPCs by Tran and coworkers [8], who showed that these
cells expressed most chemokine receptors. They then went on to
examine expression of a subset of these receptors in neurogenic
regions of the adult mouse, showing that CCR1, CCR2, CCR5,
CXCR3 and CXCR4 were expressed [19]. Less information is
available on expression of chemokines in the adult CNS, although
several are known to be expressed under basal conditions or
following neural damage/disease, including MCP1/CCL2,
MIP1a/CCL3, GROa/CXCL1, LIX/CXCL5, MCP5/CCL12,
and IP10/CXCL10 [36,37,38,39]. Expression of other chemo-
Figure 6. Effect of selected chemokines+/2IFNc on oligodendrocyte precursor maturation. The effect of chemokines (10 ng/ml)+/2IFNc
(100 U/ml) on oligodendrocyte maturation was assessed by quantifying the percentage of O4 expressing cells at 3 days (A) and 7 days (B) that had
the morphology of precursor cells, pro-oligodendrocytes or oligodendrocytes (C). Results are expressed as mean+/2sem from n=3 experiments,
*p,0.05, **p,0.01 ***p,0.01. Scale bar in C, 50 mm.
doi:10.1371/journal.pone.0025406.g006
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described in the CNS, but does not appear to be on CNS
parenchymal cells, and rather on infiltrating immune cells or
endothelial cells [24].
We have now shown that of all adult neural regions, the olfactory
bulb expresses almost all chemokine receptors and most CXC
chemokines at the highest levels, with variable expression of
receptors in the other neurogenic regions, the SVZ and hippocam-
pus. Non-neurogenic cortex expressed very few of the chemokine
receptors and of those that were expressed, they were at low levels
compared to the neurogenic brain regions. Unexpectedly, given the
relatively restricted expression of the chemokine receptors, there
was quite widespread expression of CXC chemokine mRNA,
including in cortex. CXCR4 expression could be detected in our
cortical samples, indicative of physiological effects of CXCL12, as
previously shown [11,40,41,42,43,44]. The role of the other CXC
chemokines in non-neurogenic cortex under basal conditions is
thereforenot clear,althoughthey mayactonreceptorsexpressedby
a small number of cells in the cortex, such as endothelial cells and
below the detection limit of RT-PCR under the conditions used.
However, this was also observed in SVZ and hippocampus, where
chemokines were expressed while their receptors were not, e.g.
CXCL1 in hippocampus, which did not express the receptor
CXCR2, or CXCL13 in SVZ, which did not express the receptor
CXCR5.Thismayindicate that expression of these chemokines has
paracrine effects on surrounding tissue or that there are as yet
unidentified ligand/receptor pairings. Conversely, chemokine and
cognate receptor expression in the olfactory bulb was widespread
and indicates a large physiological role induced by autocrine or
paracrineproduction of chemokinesunder physiological conditions.
Regulation of chemokine and receptor expression in
adult neurospheres by inflammatory cytokines
IFNc and/or TNFa did not upregulate expression of any of the
chemokine receptors in the neurospheres and, if anything,
decreased their expression, particularly for the CC receptors.
This is in contrast to astrocytes, where inflammatory stimulation
upregulated CCR7 expression [45], but which may have been in
response to stimuli other than IFNc and/or TNFa. Further, other
cytokines, such as IL10 and IL-4, upregulate chemokine receptor
expression on NPCs [46], indicating that different inflammatory
mediators regulate chemokine and chemokine receptor expression
in NPCs. Surprisingly, expression of very few of the chemokines
examined was upregulated by IFNc and/or TNFa. The notable
exceptions were CXCL1, which was upregulated by TNFa,
CXCL9 which was upregulated by IFNc, CCL2, which was
upregulated by IFNc and TNFa and further enhanced by the
combination of the two, and CXCL13, which was only
upregulated by a combination of IFNc and TNFa. Interestingly,
CXCL10 and CXCL11 expression was not upregulated in the
mouse NPCs, even though, like CXCL9, they are IFNc inducible
in other cell types, such as astrocytes and microglia, which also
exhibited cell-type specific differential induction of expression by
IFNc [47]. Therefore, there are cell-type specific responses to
inflammatory cytokines in terms of regulation of chemokine
expression, indicating possible different functions of these induced
chemokines in the different cell types. The inflammatory neural
environment could therefore have different effects on NPCs versus
their differentiated progeny.
Regulation of NPC differentiation
Similar to previous reports [22,23,48] we found that CCL2
promoted neuronal differentiation. We found that CXCL9 and
CCL21 also promoted neuronal differentiation. Given that IFNc
promotes neuronal differentiation of adult NPCs [16] and we show
here that IFNc induces CXCL9, as well as CCL2 expression, it
raises the possibility that the effect of IFNc on neuronal
differentiation of NPCs is indirect, through induction of CXCL9
and CCL2. These same chemokines had no effect on astrocyte or
total oligodendrocyte numbers. However, they promoted oligo-
dendrocyte maturation, particularly in conjunction with IFNc.
CXCL9 and CXCL1 promoted early oligodendrocyte maturation
with effects by day 3 that were gone by day 7, while conversely
CCL2 had longer term effects, only promoting oligodendrocyte
maturation by day 7. This suggests that their mechanism of action
may be different or possibly that early forced maturation of the
pro-oligodendrocytes also led to decreased survival of the mature
cells. CXCL1 has also been shown to promote oligodendrocyte
precursor proliferation [49,50] and migration arrest [51], with
decreased numbers of oligodendrocytes and decreased myelination
in CXCR2 null mice [52] and increased numbers and remyelina-
tion in mice that overexpress CXCL1 following experimental
allergic encephalomyelitis (EAE) [53]. Therefore, CXCL1 plays
diverse roles in regulation of oligodendrocyte precursor biology. A
role for CXCL9 is less established. CXCR3 null mice show
increased demyelination in a model of EAE [54]. This involves
regulation of T cells in the nervous system, but in light of the
effects of CXCL9 shown here on oligodendrocyte maturation,
may also reflect a decreased ability of oligodendrocyte precursor
cells to mature as the CXCR3 null cells can no longer respond to
the CXCR3 ligand, CXCL9.
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